TRAINING ARTICLE
Fierce Pharma
NOVEMBER 27, 2023
THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.
Fierce Pharma
NOVEMBER 27, 2023
THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.
Rethinking Clinical Trials
JANUARY 31, 2023
For more, read the full article , and see the Living Textbook chapter on Data Sharing and Embedded Research. The post January 31, 2023: New Article Suggests Moving From Idealism to Realism With Data Sharing appeared first on Rethinking Clinical Trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
MAY 11, 2023
A new article from the NIH Pragmatic Trials Collaboratory outlines stakeholder insights and ethical considerations related to sharing deidentified, participant-level data in pragmatic clinical trials. The article was published this month in Learning Health Systems. Read the full report.
Intouch Solutions
DECEMBER 1, 2023
Recently, Ad Forum published an article highlighting five campaigns it found to be “ Raising the Bar for Health Equity in Advertising.” And, you can read the Ad Forum article here ! One was our ongoing work with The Chrysalis Initiative, a nonprofit working to eliminate racial disparities in breast cancer treatment.
Rethinking Clinical Trials
JULY 18, 2022
A new article in Academic Emergency Medicine fills the gap by providing recommendations for the design of PCTs in emergency settings. Read the full text of the article. The post July 18, 2022: New Article Offers Recommendations for Pragmatic Trials in Emergency Medicine appeared first on Rethinking Clinical Trials.
Drug Discovery World
NOVEMBER 16, 2023
A new digital article is now available to download entitled ‘ A comprehensive approach to immunophenotyping for targeted drug discovery and development’ With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies.
Velocity Clinical Research
NOVEMBER 20, 2023
Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG , is the lead author of an article recently published in the New England Journal of Medicine. The article highlights the results of a Phase 3 trial of elafibranor for the treatment primary biliary cholangitis, an autoimmune disease that causes inflammation and damage of the bile ducts in the liver.
Let's personalize your content